16 Aug 2019 11:08
Consort Medical plc (the 'Company')
Director/PDMR shareholding
16 August 2019
Consort Medical plc announces that Jonathan Glenn, CEO, has exercised awards over ordinary shares in the Company ('Ordinary Shares') in accordance with the terms of the Consort Medical plc Deferred Bonus Plan (the 'DBP') and the Consort Medical Performance Share Plan (the 'PSP') (together the 'Awards').
The Awards were exercised for nil consideration on 14 August 2019 pursuant to respective awards made on 21 June 2016.
The exercise of the Awards was satisfied out of the Ordinary Shares held in the Consort Medical plc Employee Share Ownership Trust.
Also on 14 August 2019, Mr Glenn disposed of Ordinary Shares at £7.26 per share with the net proceeds of the disposal used to cover tax liabilities associated to the above exercise of the Awards only. Mr Glenn's increased resultant interest in the Ordinary Shares of the Company is shown below.
Individual | Director /PDMR | Ordinary Shares exercised under the DBP | Ordinary Shares exercised under the PSP | Total Ordinary Shares exercised
| Total Ordinary Shares sold
| Total Ordinary shares retained | Total resultant Ordinary Shares held | % of Ordinary Share capital held |
Jonathan Glenn | Director | 19,207 | 12,510 | 31,717 | 14,908 | 16,809 | 183,537 | 0.37 |
The Company was informed of the above transaction by the Consort Medical Employee Share Ownership Trust on 14 August 2019.
Mr Glenn's resultant beneficial shareholding of 183,537 Ordinary Shares equates to 2.6x multiple of his salary (calculated using the exercise share price of £7.26 per share).
Enquiries: Michelle Palmer Assistant Company Secretary 01442 867920
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Jonathan Glenn | |||
2 | Reason for the notification | ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment | Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name | Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| 1. Exercise of Deferred Bonus Plan and Performance Share Plan shares 2. Sale of Deferred Bonus Plan and Performance Share Plan shares to cover the Tax and NI liabilities associated with the exercise of the Awards | |||
c)
| Price(s) and volume(s) |
|
|
|
|
| Price(s) | Volume(s) |
| ||
| 1. £0.00 | 31,717 |
| ||
| 2. £7.26 | 14,908 |
| ||
|
|
|
| ||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 14 August 2019 | |||
f)
| Place of the transaction
| Off market transaction | |||